S100A8 and gastric cancer: Treatment with the ferroptosis inhibitors deferoxamine (DFO) and liproxstatin-1 can rescue the sensitivity of CagA-induced cells to RSL3 and erastin, suggesting a potential therapeutic strategy for inducing ferroptosis in GC patients infected with CagA+ H. pylori strain [49].